Search

Lunyi Lao

Supervisory Patent Examiner (ID: 13731, Phone: (571)272-7671 , Office: P/2692 )

Most Active Art Unit
2673
Art Unit(s)
2673, 2619, 2774, 2621, 4134, 2609, 2692, 2629, 2677, 2778
Total Applications
784
Issued Applications
576
Pending Applications
47
Abandoned Applications
164

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 1448926 [patent_doc_number] => 06455046 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-24 [patent_title] => 'Use of mCRP to enhance immune responses' [patent_app_type] => B1 [patent_app_number] => 09/567954 [patent_app_country] => US [patent_app_date] => 2000-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7663 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/455/06455046.pdf [firstpage_image] =>[orig_patent_app_number] => 09567954 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/567954
Use of mCRP to enhance immune responses May 8, 2000 Issued
09/560365 Novel polynucleotides expressed in activated T-lymphocytes and proteins encoded thereby Apr 27, 2000 Abandoned
Array ( [id] => 1601870 [patent_doc_number] => 06476211 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-05 [patent_title] => 'Methods and materials relating to CD39-like polypeptides' [patent_app_type] => B1 [patent_app_number] => 09/557800 [patent_app_country] => US [patent_app_date] => 2000-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 49599 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/476/06476211.pdf [firstpage_image] =>[orig_patent_app_number] => 09557800 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/557800
Methods and materials relating to CD39-like polypeptides Apr 24, 2000 Issued
Array ( [id] => 1375895 [patent_doc_number] => 06562943 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-13 [patent_title] => 'Peptide epitopes recognized by disease promoting CD4 T lymphocytes' [patent_app_type] => B1 [patent_app_number] => 09/552802 [patent_app_country] => US [patent_app_date] => 2000-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 21238 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/562/06562943.pdf [firstpage_image] =>[orig_patent_app_number] => 09552802 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/552802
Peptide epitopes recognized by disease promoting CD4 T lymphocytes Apr 19, 2000 Issued
Array ( [id] => 1361909 [patent_doc_number] => 06565848 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-20 [patent_title] => 'Cadherin-like asymmetry protein-1, and methods for its use' [patent_app_type] => B1 [patent_app_number] => 09/546934 [patent_app_country] => US [patent_app_date] => 2000-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 23 [patent_no_of_words] => 31772 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/565/06565848.pdf [firstpage_image] =>[orig_patent_app_number] => 09546934 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/546934
Cadherin-like asymmetry protein-1, and methods for its use Apr 10, 2000 Issued
Array ( [id] => 1212532 [patent_doc_number] => 06709864 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-23 [patent_title] => 'Adipogenic differentiation of human mesenchymal stem cells' [patent_app_type] => B1 [patent_app_number] => 09/537003 [patent_app_country] => US [patent_app_date] => 2000-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 38 [patent_no_of_words] => 8898 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/709/06709864.pdf [firstpage_image] =>[orig_patent_app_number] => 09537003 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/537003
Adipogenic differentiation of human mesenchymal stem cells Mar 27, 2000 Issued
09/534966 Single chain class I major histocompatibility complexes, constructs encoding same and methods of generating same Mar 26, 2000 Abandoned
Array ( [id] => 7643753 [patent_doc_number] => 06429287 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-06 [patent_title] => 'Isolated molecules which complex with HLA-Cw*16 molecules, and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/495562 [patent_app_country] => US [patent_app_date] => 2000-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6132 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/429/06429287.pdf [firstpage_image] =>[orig_patent_app_number] => 09495562 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/495562
Isolated molecules which complex with HLA-Cw*16 molecules, and uses thereof Jan 31, 2000 Issued
Array ( [id] => 1523264 [patent_doc_number] => 06352723 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-05 [patent_title] => 'Brain-derived alkali-soluble immunoregulatory composition' [patent_app_type] => B1 [patent_app_number] => 09/494978 [patent_app_country] => US [patent_app_date] => 2000-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 6523 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/352/06352723.pdf [firstpage_image] =>[orig_patent_app_number] => 09494978 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/494978
Brain-derived alkali-soluble immunoregulatory composition Jan 30, 2000 Issued
Array ( [id] => 4240325 [patent_doc_number] => 06166186 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-26 [patent_title] => 'Monoclonal antibody which binds to a human-Th2-specific protein and hybridoma' [patent_app_type] => 1 [patent_app_number] => 9/480784 [patent_app_country] => US [patent_app_date] => 2000-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11563 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/166/06166186.pdf [firstpage_image] =>[orig_patent_app_number] => 480784 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/480784
Monoclonal antibody which binds to a human-Th2-specific protein and hybridoma Jan 9, 2000 Issued
09/479508 Expression and export of anti-obesity proteins as Fc fusion proteins Jan 6, 2000 Abandoned
Array ( [id] => 1483810 [patent_doc_number] => 06365155 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-02 [patent_title] => 'Ancrod-specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same' [patent_app_type] => B1 [patent_app_number] => 09/446983 [patent_app_country] => US [patent_app_date] => 1999-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5071 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/365/06365155.pdf [firstpage_image] =>[orig_patent_app_number] => 09446983 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/446983
Ancrod-specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same Dec 29, 1999 Issued
09/446464 PEPTIDES DERIVED FROM COMPLEMENT PEPTIDE C3A SEQUENCE AND ANTIALLERGIC COMPOSITIONS COMPRISING THEM Dec 21, 1999 Abandoned
09/465321 METHOD AND APPARATUS FOR THE PRODUCTION OF SOLUBLE MHC ANTIGENS Dec 16, 1999 Abandoned
Array ( [id] => 1596084 [patent_doc_number] => 06384190 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-07 [patent_title] => 'Isolated decapeptides which bind to HLA molecules' [patent_app_type] => B1 [patent_app_number] => 09/461083 [patent_app_country] => US [patent_app_date] => 1999-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7066 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/384/06384190.pdf [firstpage_image] =>[orig_patent_app_number] => 09461083 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/461083
Isolated decapeptides which bind to HLA molecules Dec 13, 1999 Issued
Array ( [id] => 7636702 [patent_doc_number] => 06379953 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-30 [patent_title] => 'Ligands that modulate differentiation of mesenchymal stem cells' [patent_app_type] => B1 [patent_app_number] => 09/452142 [patent_app_country] => US [patent_app_date] => 1999-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 8266 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/379/06379953.pdf [firstpage_image] =>[orig_patent_app_number] => 09452142 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/452142
Ligands that modulate differentiation of mesenchymal stem cells Nov 30, 1999 Issued
Array ( [id] => 4364416 [patent_doc_number] => 06274329 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-14 [patent_title] => 'Method for the detecting thyroid autoantibodies' [patent_app_type] => 1 [patent_app_number] => 9/380732 [patent_app_country] => US [patent_app_date] => 1999-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3836 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/274/06274329.pdf [firstpage_image] =>[orig_patent_app_number] => 380732 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/380732
Method for the detecting thyroid autoantibodies Nov 22, 1999 Issued
09/443638 Inhibition therapy for septic shock with mutant cd14 Nov 17, 1999 Abandoned
Array ( [id] => 1490590 [patent_doc_number] => 06417165 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-09 [patent_title] => 'NY-ESO-1-peptide derivatives, and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/440621 [patent_app_country] => US [patent_app_date] => 1999-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6376 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/417/06417165.pdf [firstpage_image] =>[orig_patent_app_number] => 09440621 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/440621
NY-ESO-1-peptide derivatives, and uses thereof Nov 14, 1999 Issued
09/438136 Method for the production of non-immunogenic proteins Nov 9, 1999 Abandoned
Menu